| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |